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Abstract
Background: Treatment of alcohol use disorders (AUDs) is characterized by an adherence rate below 50%. Clinical research
has found that patient adherence enhances treatment effect; hence, health authorities, clinicians, and researchers strive to explore
initiatives contributing to patients receiving treatment. Concurrently, videoconferencing-based treatment is gaining ground within
other addiction and psychiatric areas.
Objective: The aim of this study was to test whether optional videoconferencing increases adherence to and effectiveness of
AUD treatment in a randomized controlled trial (RCT). We hypothesized that the intervention would decrease premature dropout
(the primary outcome), as well as increase successful treatment termination, treatment duration, and treatment outcome (secondary
outcomes).
Methods: We conducted this study in the public outpatient alcohol clinic in Odense, Denmark, between September 2012 and
April 2013. It was an RCT with 2 groups: treatment as usual (TAU) and treatment as usual with add-on intervention (TAU+I).
The TAU+I group had the option, from session to session, to choose to receive treatment as usual via videoconferencing. Data
consisted of self-reported responses to the European version of the Addiction Severity Index (EuropASI). We collected data at
baseline, at follow-up at 3, 6, and 12 months, and at discharge.
Results: Among consecutive patients attending the clinic, 128 met the inclusion criteria, and 71 of them were included at
baseline. For the primary outcome, after 180 days, 2 of 32 patients (6%) in the TAU+I group and 12 of 39 patients (31%) in the
TAU group had dropped out prematurely. The difference is significant (P=.008). After 365 days, 8 patients (25%) in the TAU+I
group and 17 patients (44%) in the TAU group had dropped out prematurely. The difference is significant (P=.02). For the
secondary outcomes, significantly more patients in the TAU+I group were still attending treatment after 1 year (P=.03). We found
no significant differences between the 2 groups with regard to successful treatment termination and treatment outcome.
Conclusions: The results indicate that offering patients optional videoconferencing may prevent premature dropouts from
treatment and prolong treatment courses. However, the small sample size precludes conclusions regarding the effect of the
intervention, which was not detectable in the patients’ use of alcohol and severity of problems.
Trial Registration: The Regional Health Research Ethics Committee System in Denmark: S-20110052;
https://komite.regionsyddanmark.dk/wm258128 (Archived by WebCite at http://www.webcitation.org/6tTL3CO6u)
(JMIR Ment Health 2017;4(3):e38)   doi:10.2196/mental.6713
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Introduction
Treatment of alcohol use disorders (AUDs) is characterized by
an adherence rate below 50% [1,2], with 50% of the patients
dropping out within the first month of treatment [3,4]. Clinical
research has found that the largest alcohol behavior change
occurs at the beginning of a treatment course [5] and that patient
adherence enhances treatment effect [6]. Hence, health
authorities, clinicians, and researchers strive to explore initiatives
contributing to patients receiving the planned amount of
treatment. Even though research on the optimal duration of
treatment is sparse, to our knowledge, no studies found evidence
for an increased effect of longer treatment courses compared
with shorter courses, such as 3 and 6 months [7-9]. The Danish
clinical guideline for the treatment of alcohol dependence [10]
recommends a 3-month course of therapy with the possibility
of extension. However, most treatment institutions in Denmark
have, so far, recommended 6 months of treatment in general or
even longer, and this is still often the case.
Videoconferencing-based treatment, either alone or combined
with face-to-face treatment such as blended care, has shown
great potential for enhancing treatment and recovery within
substance use and psychiatric areas, as it decreases barriers of
time and distance [11,12]. The field of videoconferencing-based
treatment of AUDs is relatively new, and the few existing studies
were predominantly small pilot and feasibility studies, which
found high levels of patient satisfaction and acceptance [13-19].
Furthermore, they found that videoconferencing may offer the
potential to meet some of the challenges AUD treatment is
facing regarding barriers [15,16], especially for patients who
live at a considerable distance from the clinics [17-19] or have
other psychiatric diagnoses [14]. Moreover, these earlier studies
found videoconferencing-based assessment and treatment to be
highly credible [13,14] and even as effective as face-to-face
treatment, with similar relapse and attrition rates [13].
In supplement to the existing studies on
videoconferencing-based treatment of AUDs, we have conducted
a small randomized controlled trial (RCT) in a real-life setting.
The purpose was to examine the effectiveness of optional
videoconferencing-based AUD treatment on a laptop with
wireless Internet and a videoconferencing client. To our
knowledge, this is the first study where AUD patients could opt
in on videoconferencing for as many sessions as they chose.
However, studies regarding Web-based blended therapy for
psychiatric disorders have, for example, examined designs with
optional modules [20], with the opportunity to step up treatment
if the patient felt it was necessary [21], and using a personal
blend [22], enhancing patients’ self-management [12]. Similarly,
a qualitative study nested within the RCT found that patients
being offered videoconferencing may have experienced it as a
means to enhance their autonomy and empowerment, with the
ability to choose freely between the two formats having a
positive impact on the treatment course [23]. Also, a mixed
methods study linked to the RCT found that patients felt more
satisfied with the treatment and prolonged their treatment
courses when they had the opportunity to receive sessions via
videoconferencing [24]. Therefore, it seems highly relevant to
examine whether the opportunity of receiving all or some of
the treatment course by means of videoconferencing can increase
adherence to, and thereby the effectiveness of, AUD treatment.
Aim
The aim of this study was to test whether optional
videoconferencing increases adherence to and effectiveness of
AUD treatment in an RCT.
Hypotheses
We hypothesized that the intervention would decrease the
number of patients who dropped out prematurely. We tested
this by measuring premature dropout at 6-month follow-up (the
primary outcome). Additionally, we hypothesized that the
intervention would increase the number of patients terminating
their treatment course successfully, increase the proportion of
patients still attending a treatment course after 6 months from
45% to 70%, and increase treatment outcome. We tested this
by measuring successful treatment termination, treatment
duration, and the difference in alcohol characteristics from
baseline to 1 year into the treatment course (secondary
outcomes).
Methods
Design
The study was an RCT with 2 groups: treatment as usual (TAU)
and treatment as usual with add-on intervention (TAU+I).
Sample
All consecutive patients who attended the public outpatient
alcohol clinic in Odense, Denmark, between September 2012
and April 2013 were eligible to participate in the study. Inclusion
criteria were age 18 years or older, harmful alcohol use or
alcohol dependence syndrome according to the International
Classification of Diseases, Tenth Revision (ICD-10), and written
informed consent. Exclusion criteria were dementia, psychoses,
and lack of sufficient Danish language skills. We registered the
study with The Regional Committees on Health Research Ethics
for Southern Denmark (S-20110052; Multimedia Appendix 1
[25]).
Setting
In the outpatient clinic, an interdisciplinary team of social
workers, nurses, and psychiatrists conducts the AUD treatment,
based on clinical guidelines [26]. The treatment is free of charge
and based on face-to-face therapy sessions and pharmacology,
if needed [27]. At the beginning of the treatment course, the
patients are offered detoxification and motivational interviewing
[28]. When they are free of withdrawal symptoms and if they
decide to attend a psychosocial treatment course, the patients
undergo an assessment interview using the European version
of the Addiction Severity Index (EuropASI) [29,30]. Based on
an algorithm using the results of the assessment interview,
consultant psychiatrists refer the patients to individual
psychosocial treatment. This may consist of cognitive behavioral
therapy, supportive consultations, family therapy, or contract
treatment [31]; as such, there is no difference in the effect of
each offer. Treatment is conducted by well-trained and closely
supervised nurses and social workers. The length of each
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treatment course is individually planned. The duration of a
typical successful treatment course is about 7 months. One
treatment session lasts between 30 and 60 minutes. Session
frequency is 1 to 3 times a week at the beginning of the course
and 1 session every other week later in the course [32].
Recruitment and Randomization
We recruited patients during the assessment interview and
systematically offered participation to consecutive patients who
decided to attend a psychosocial treatment course and met the
inclusion criteria. We included patients who decided to
participate in the study and randomly assigned them during the
assessment interview; we were aiming at recruiting 140 patients,
with 70 in each group. Randomization was carried out by the
administrative staff, who were not affiliated with the study. The
patients drew a nontransparent envelope packed by an
independent person. The envelope contained information about
their group placements, either the TAU group or the TAU+I
group, with their entailments. Figure 1 shows the recruitment
and randomization process.
Figure 1. Flowchart of the recruitment process. TAU: treatment as usual; TAU+I: treatment as usual with add-on intervention.
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Treatment as Usual
The TAU group received treatment as usual face-to-face at the
clinic. Treatment was conducted as described in the Setting
section above, according to clinical guidelines.
Treatment as Usual With Add-On Intervention
The TAU+I group also received treatment as usual. In addition,
they were offered optional videoconferencing and were, from
session to session, able to choose to receive treatment as usual
via videoconferencing. Hence, the offer of receiving treatment
by optional videoconferencing was the intervention in this study.
We chose this approach, of patients opting in on
videoconferencing as opposed to having all patients receive
treatment via videoconferencing, in order to offer the patients
the opportunity to make the choices. Each patient in the TAU+I
group was equipped with a laptop with wireless Internet and a
Cisco TelePresence videoconferencing client (Cisco Systems,
Inc, San Jose, CA, USA). Prior to scheduling the first treatment
session, we instructed the patients in the use of the equipment
and conducted a test to ensure that the equipment was fully
functional. Before each therapy session, the patients had the
choice between treatment as usual at the clinic and treatment
as usual via videoconferencing from any location. If the patients
opted for a session via videoconferencing, they just needed to
turn on the equipment. If the therapist went to fetch the patients
from the waiting room, only to discover them absent, the
therapist would then call them via videoconferencing.
Measures
The Addiction Severity Index (ASI) was developed especially
for assessment, treatment, and research in addiction [29,33].
Studies have demonstrated the ASI to be a valid instrument
[34,35]. The EuropASI [30] provides sociodemographics,
alcohol measures, and composite scores for 9 potential problem
areas in the patients’ life circumstances. The composite scores
reflect the severity of the problems during the last month
preceding the assessment interview. The composite scores range
from 0 to 1; the higher the score, the greater the severity [29].
Baseline measures were EuropASI sociodemographics about
age, sex, higher/continuing education, employment, and
cohabitation; EuropASI alcohol measures regarding dependence,
age at onset of excessive use of alcohol (≥5 units a day, at least
3 days a week during the last 30 days), years of excessive
alcohol use in life, days of alcohol use in the past month, and
days of excessive alcohol use in the past month; and EuropASI
composite scores regarding alcohol use, drug use, economic
status, employment, legal status, family status, social status,
medical status, and psychiatric status. The composite scores
were computed according to the EuropASI [30].
The primary outcome was premature dropout at the 6-month
follow-up. Secondary outcomes were successful treatment
termination, treatment duration (measured by the number of
days in treatment), and alcohol characteristics, consisting of
12-month follow-up alcohol use and severity (measured by the
number of days of alcohol use and excessive alcohol use in the
past month preceding the interview), and composite scores
regarding alcohol use, employment, legal status, family status,
medical status, and psychiatric status.
Data Collection
Baseline data were collected by the therapists at the assessment
interview at treatment start prior to the randomization. Follow-up
data were collected by the therapists as part of the routine
treatment course as long as the patients attended treatment, at
the status sessions at 3, 6, and 12 months, and at discharge. We
collected additional 1-year follow-up data. To collect the data,
we used letters, telephone calls, and personal contacts to secure
the highest possible participation rate [36].
In addition, we collected data on the actual use of
videoconferencing, and from questionnaires on nonparticipation
and satisfaction, and semistructured interviews with participants
in the TAU+I group, therapists, and collaborators. We used
these additional data for separate analyses of nonparticipation,
satisfaction, patient perspectives, and therapist perspectives on
the use of videoconferencing.
Statistics
We conducted the analyses in this study using SAS Enterprise
Guide 7.1 (SAS Institute Inc) and Stata v14 (StataCorp LLC).
The power was calculated in Stata. The primary outcome was
the number of patients still attending treatment 6 months after
the assessment interview. The calculation was based on numbers
from the clinic in 2010 showing that the proportion of patients
still attending treatment after 7 months was 45%. We expected
the intervention to increase the proportion of patients still
attending a treatment course after 6 months from 45% to 70%.
For a significance level of 5% and a power of 80%, 140 patients
should be included, with 70 in each group.
Baseline variables, sex, higher/continuing education,
employment, cohabitation, and dependence were categorical;
hence, we used Pearson chi-square tests for relationships
between variables. The variables higher/continuing education
and dependence had an expected frequency of 5 or less in one
cell; hence, we used Fisher exact test. The rest of the variables
were continuous; hence, we used the Shapiro-Wilk W test for
normal data to check for normally distributed data. None of the
continuous variables were normally distributed; hence, we used
2-sample Wilcoxon rank sum (Mann-Whitney) tests to compare
the means of not normally distributed interval-dependent
variables for 2 independent groups.
We tested the primary outcome, premature dropout at 6-month
follow-up, by means of a Kaplan-Meier survival analysis using
Wilcoxon test statistics.
Secondary outcomes were regarding successful treatment
termination, treatment duration, and alcohol characteristics. We
tested successful treatment termination by means of a logistic
regression analysis. We tested treatment duration by means of
a Kaplan-Meier survival analysis at 6-month and 12-month
follow-ups. We tested differences in alcohol characteristics from
baseline to 1-year follow-up using per-protocol analyses;
however, due to missing data, we used last observation carried
forward. The variables were continuous; hence, we used the
Shapiro-Wilk W test for normal data to check for normally
distributed data. The variable employment was normally
distributed; hence, we used a 2-sample t test with equal variances
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to compare means. The rest of the continuous variables were
not normally distributed; hence, we used 2-sample Wilcoxon
rank sum (Mann-Whitney) tests to compare means. We made
no corrections for multiple comparisons.
Results
Participants
Our goal was to recruit 140 participants, but we succeeded in
recruiting only 71 participants. As the flowchart in Figure 1
shows, 128 consecutive patients entered psychosocial AUD
treatment during the period of recruitment. A total of 47 patients
declined to participate in the study, 3 patients were assigned to
another treatment, and 1 patient was discharged before giving
notice. After inclusion, a further 4 patients withdrew from the
study, and data were missing for 2. Hence, only 71 patients
completed the baseline assessment interview and were randomly
assigned: 39 patients to the TAU group and 32 patients to the
TAU+I group.
Table 1. Baseline sample characteristics, by randomization group (N=71).
P valueTAU+Ib group (n=32)TAUa group (n=39)Characteristics
EuropASIc sociodemographics
.6446.0 (13.5)47.3 (12.4)Age in years, mean (SD)
.819 28)10 (26)Sex (female), n (%)
.3628 (88)30 (77)Higher/continuingd education (yes), n (%)
.1511 (34)20 (51)Employede (yes), n (%)
.6020 (63)22 (56)Cohabiting (yes), n (%)
EuropASI alcohol measures
.7428 (87)32 (82)Alcohol dependencef (yes), n (%)
.7332.25 (14.83)31.31 (13.72)Age in years at onset of excessiveg use of alcohol, mean (SD)
.0913.09 (11.79)16.28 (10.51)Years of excessive alcohol use in life, mean (SD)
.4420.44 (10.37)18.44 (10.89)Days of alcohol use in the past month, mean (SD)
.3118.25 (10.24)15.54 (11.53)Days of excessiveg alcohol use in the past month, mean (SD)
EuropASI composite scoresh
.510.72 (0.19)0.68 (0.22)Alcohol use, mean (SD)
.10.05 (0.12)0.02 (0.08)Drug use, mean (SD)i
.330.65 (0.45)0.54 (0.45)Economic status, mean (SD)
.540.44 (0.39)0.38 (0.41)Employment, mean (SD)
.240.04 (0.15)0.01 (0.04)Legal status, mean (SD)j
.090.11 (0.21)0.22 (0.27)Family status, mean (SD)
.900.08 (0.19)0.08 (0.19)Social status, mean (SD)j
.940.29 (0.39)0.29 (0.40)Medical status, mean (SD)
.800.24 (0.26)0.20 (0.20)Psychiatric status, mean (SD)
aTAU: treatment as usual.
bTAU+I: treatment as usual with add-on intervention.
cEuropASI: European version of the Addiction Severity Index.
dSome respondents with continuing education attended high school first; some did not.
eNot necessarily full time.
fAccording to the International Classification of Diseases, Tenth Revision (ICD-10).
g≥5 units a day in at least 3 days a week during the last 30 days.
hEuropASI composite scores vary from 0 (no problem) to 1 (extreme problem) in the 30 days preceding the interview.
iOn the basis of 69 observations.
jOn the basis of 70 observations.
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Baseline
Table 1 shows baseline characteristics of the participants. The
2 groups received the same variation of treatment offers. The
average participant was about 47 years old, most were male,
and more than half were cohabiting. A majority had
higher/continuing education but less than 50% were employed.
More than 80% had a diagnosis of alcohol dependence syndrome
according to the ICD-10. The 2 groups did not deviate from
each other according to EuropASI sociodemographics, alcohol
measures, and composite scores. It seems that the allocation of
patients to the 2 groups resulted in 2 similar groups with regard
to sociodemographic and alcohol characteristics. Therefore, we
assumed that the randomization was successful.
Use of Videoconferencing
Records of the use of the intervention showed that 16 of the 32
patients (50%) in the TAU+I group used the laptop with
videoconferencing for a total of 60 treatment sessions; however,
37 (62%) of the sessions had technical problems. Mostly, these
problems consisted of poor sound quality, which was solved by
using telephones for the sound.
Primary Outcome: Premature Dropout
The termination status of the patients in this study fell into 2
categories. The first category is premature dropout, consisting
of patients who did not appear at the discharging session but
were expected to return, patients who were discharged after not
appearing at the treatment sessions, and patients who were
discharged by their own wish (at a time considered by the
therapist as being too early).
Figure 2 shows premature dropout by the means of a survival
analysis. The plot shows the number of days the TAU group
and the TAU+I group stayed in treatment or the number who
successfully terminated treatment. After 180 days in treatment,
2 of 32 patients (6%) in the TAU+I group and 12 of 39 patients
(31%) in the TAU group had dropped out prematurely. The
difference is significant (P=.008). After 365 days, 8 patients
(25%) in the TAU+I group and 17 patients (44%) in the TAU
group had dropped out prematurely. The difference is significant
(P=.02).
Secondary Outcomes
Successful Treatment Termination
The second category of termination status is successful treatment
termination, consisting of patients who completed their treatment
course as planned or still were in treatment at the discharging
session. Upon completion of their treatment course, 21 of 39
patients (54%) in the TAU group and 19 of 32 patients (59%)
in the TAU+I group had successfully terminated treatment. The
difference is not significant (P=.64). The crude odds ratio for
successful termination is 1.25 (95% CI 0.48-3.25) for the TAU+I
group. When adjusted for employment and sex, the odds ratio
for successful termination is 1.57 (95% CI 0.57-4.37).
Treatment Duration
Figure 3 shows that after 6 months, 24 of 32 patients (75%) in
the TAU+I group and 24 of 39 patients (62%) in the TAU group
were still attending treatment. After 1 year, 14 of 32 (44%)
patients in the TAU+I group and 7 of 39 (18%) patients in the
TAU group were still in treatment. The difference is significant
(P=.03).
Figure 2. Primary outcome: premature dropout; survival curves (P=.008; successful terminations censored), by randomization group (N=71; treatment
as usual [TAU] group: n=39; treatment as usual with add-on intervention [TAU+I] group: n=32).
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Figure 3. Secondary outcome: treatment duration; survival curves (P=.03), by randomization group (N=71; treatment as usual [TAU] group: n=39;
treatment as usual with add-on intervention [TAU+I] group: n=32).
Table 2. Changes from baseline to 12-month follow-up, by randomization group (N=71).
P valueTAU+Ib group (n=32)TAUa group (n=39)Measures
EuropASIc alcohol measures
.64–13.75 (12.40)–12.44 (10.53)Days of alcohol use in the past month prior to interviews, mean (SD)
.68–13.47 (11.79)–12.26 (11.29)Days of excessived alcohol use in the past month prior to interviews, mean (SD)
EuropASI composite scorese
.59–0.49 (0.33)–0.48 (0.26)Alcohol use, mean (SD)
.97–0.05 (0.42)–0.05 (0.33)Employment, mean (SD)
.21–0.01 (0.05)–0.01 (0.03)Legal status, mean (SD)f
.52–0.02 (0.25)–0.09 (0.25)Family status, mean (SD)
.14–0.03 (0.21)0.07 (0.42)Medical status, mean (SD)g
.420.00 (0.21)–0.04 (0.24)Psychiatric status, mean (SD)
aTAU: treatment as usual.
bTAU+I: treatment as usual with add-on intervention.
cEuropASI: European version of the Addiction Severity Index.
d≥5 units a day in at least 3 days a week during the last 30 days.
eEuropASI composite scores vary from 0 (no problem) to 1 (extreme problem) in the 30 days preceding the interview.
fOn the basis of 70 observations.
gOn the basis of 69 observations.
Alcohol Characteristics
Table 2 shows differences from baseline to 1-year follow-up
for selected alcohol measures and composite scores. We found
no significant differences.
Discussion
The results of this study indicate that the offer of optional
videoconferencing may prevent premature dropout, in which
patients attend only the first couple of sessions and then drop
out. One reason why patients in the TAU+I group had
significantly fewer premature dropouts may have been that they
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were more satisfied with their treatment course, having been
given the opportunity to choose (before each session) whether
to receive treatment via videoconferencing [24]. This may have
led to increased experiences of flexibility and autonomy, making
the patients feel more empowered [23], which, in turn, may
have prevented dropouts. Similar notions were reported in a
study on Web-based blended care therapy, where patients had
positive perceptions of the Web-based sessions, especially
regarding enhancing their self-management [12]. Hence,
videoconferencing may have encouraged adherence to treatment
and prevented premature dropouts. This is especially interesting,
since previous research found that the largest alcohol behavior
change occurred at the beginning of a treatment course [5].
Previous research also found that patient groups with a general
lack of dependability (eg, no job stability, psychiatric illness,
and prior discharges from hospitals) tend to drop out
prematurely. However, patients functioning too poorly or too
well may both equally increase dropout rates. This study
investigated videoconferencing as a means to reduce premature
dropout, but videoconferencing is, of course, only one of many
initiatives that may be used. Other useful examples include
reduction of waiting time at the beginning of the treatment
course [9,26], treatment matching [6,37], explanation of the
anticipated treatment [9], use of clinical guidelines [26,38-41],
a less focal and talkative therapist at the beginning of the
treatment course [9], engagement of relatives in the treatment
process [9], aggressive pursuit [9], use of attendance contracting
and prompting [42], and contact with no-shows [43].
The Danish clinical guideline for treatment of alcohol
dependence [10] recommends treatment courses of 3 months’
duration with the possibility of extension; hence, we chose to
measure 6 and 12 months after treatment start, allowing most
patients to have completed the treatment course. In 2010, 45%
of the patients attending the clinic were still in treatment after
6 months. We expected this intervention to increase this
proportion from 45% to 70%. After 6 months, 75% of the
patients in the TAU+I group were still attending treatment,
which exceeds the expected increase. However, also after 6
months, 62% of the TAU group were still attending treatment,
which well exceeds the proportion from 2010. Nonetheless, it
may be an ongoing issue to offer treatment courses that comply
with cost effectiveness; hence, in a review from 2014, Littrell
[9] explored outcome findings regarding length of treatment.
Several reviews have correlated treatment duration with outcome
and found that patients who remain in treatment longer have
better outcomes. Hence, it seems that patients who drop out
have poorer outcomes. However, some of these studies did not
consider whether the duration was shorter because of planned
termination or premature dropout. Studies where patients were
randomly assigned to longer or shorter treatment durations, and
studies comparing shorter versus longer treatment programs,
have not found any differences in outcomes, except for patients
with lower socioeconomic standing [9]. More than 80% of the
patients in this study had alcohol dependence syndrome
diagnosed according to the ICD-10. Evidently, patients with
severe drinking problems, and without social support, benefit
from treatment [9]; hence, research suggests that patients with
moderate or severe levels of alcohol dependence should be
referred to and encouraged to attend treatment [44].
Despite significantly fewer premature dropouts in the TAU+I
group, it was not possible to detect any significant differences
in the effect of the treatment after 1 year with regard to alcohol
consumption. There could be several reasons why outcome did
not differ between the 2 groups. For instance, patients without
the option of videoconferencing, but still motivated to attend
face-to-face sessions, may have been more motivated in general
and thereby produced better outcomes. In contrast, those who
had the option could have been less motivated in general, less
willing to appear face-to-face, and more willing to use the
videoconferencing option instead. Another reason may have
been that the poor technical quality of the equipment the patients
were provided with, especially the sound where phones were
often used instead, may have caused the patients to need further
sessions. This would, unintentionally, have increased treatment
duration, as these patients probably did not fully benefit from
the videoconferencing treatment sessions due to poor technical
quality and hence only maintained their treatment status quo.
Here, those who put up with the poor technical quality of the
equipment handed to them would probably have been more
motivated to change, compared with those who did not. A few
previous studies on videoconferencing-based treatment of AUDs
have addressed attendance and effect. Frueh et al found that 13
out of 14 patients who completed their study remained abstinent
throughout the treatment [13]. Staton-Tindall et al [16] found
no significant differences between the intervention group and
the comparison group receiving motivational enhancement
therapy via videoconferencing. However, sessions 3 to 5
(focusing on change) of the intervention significantly reduced
the likelihood of using alcohol by 72% and predicted fewer
drinking days, fewer drinks per week, and fewer days
experiencing problems with alcohol during the follow-up period;
however, both motivational enhancement therapy and
videoconferencing were part of the intervention [16].
Strengths and Limitations
The most important strength of this small RCT is that it was
carried out as an effectiveness study in a real-life setting, where
consecutive patients seeking ordinary AUD treatment at the
outpatient clinic were offered participation in the study. Studies
conducted among a treatment-seeking population are unique
and rarely seen. If an experimental intervention in a research
study is likely to be implemented and upscaled in real-life praxis,
it is an advantage that the research has been carried out among
alcohol patients attending an operating clinic. Effectiveness
studies generate results that can inform clinical practice [45,46],
and examination of the intervention’s effectiveness, when
implemented within an everyday clinical setting, is an important
part of establishing an evidence base for a particular treatment
[47].
However, as a consequence, the findings of this study may not
be as positive as findings from other studies with other
prerequisites. Most of the previous studies on
videoconferencing-based AUD treatment were small feasibility
studies or randomized studies with paid patient participation.
Our sample was, nevertheless, fairly similar to them regarding
sociodemographic and alcohol measures [13-15,17]. Since the
study is representative, it can be generalized to the extent of
treatment-seeking patients with harmful alcohol use or alcohol
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dependence, at the higher severity end, attending clinics in
Denmark and other countries with a similar organization of,
and distances between, clinics.
A severe limitation of this study is that we were unable to
include the number of patients estimated in the power
calculations prior to study start. The relatively low number of
participants may have been due to patient rates being lower than
expected, compared with the same time period in previous years
in the same setting. Also, it may have been due to the
participation rate being lower than expected, based on
participation rates in other studies conducted in the same setting.
In alcohol treatment and research, it is a common challenge to
recruit and maintain patients for studies, as well as for treatment
[48]. Unwillingness to participate in research studies has been
reported as becoming more and more common [36], especially
regarding studies performed over the Internet [49]. Thus, more
patients than anticipated may simply have declined participation
because of the technical element in the study. As a consequence,
the small sample size in this study is a limitation for the
significance of the results and may, thereby, have consequences
for the inferential conclusions that can be drawn from the results.
It is a huge strength that data on premature dropout and
treatment termination were available for all but 2 patients;
however, it may be a limitation that we have 1-year follow-up
data for only 66%. Prior studies have reported follow-up
participation rates below 60% with no evidence of bias [36],
and the use of last observation carried forward is a conservative
approach to secure validity. In comparison, previous studies on
videoconferencing-based AUD treatment have reported
relatively good session attendance and successful intervention
engagement, as well as completion rates similar to face-to-face
treatment [13,15,16], completion rates ranging from 50% to
almost 100% [14,15,17], and follow-up rates of up to 90%
[16,18]. This may be due to the fact that most of the prior studies
were small pilot and feasibility studies or RCTs, where
participants were even paid to participate. These recruitment
processes may have biased participation in the prior studies in
a positive direction compared with participation in effectiveness
studies like ours, where participants were consecutive patients
seeking treatment for alcohol problems in a real-life setting.
It may be a limitation to the study that the results were based
on self-reported EuropASI data. Even though general population
surveys have found alcohol consumption to be underreported,
and the accuracy of an individual’s report may be difficult to
determine, the literature suggests that, from a group perspective,
self-reports of alcohol use from clinical and nonclinical samples
are accurate provided that people are interviewed under the
following conditions: alcohol-free when interviewed; given
written assurances of confidentiality; interviewed in a setting
encouraging honest reporting; asked clearly worded objective
questions; and provided with memory aids [50].
Furthermore, it may be a limitation to this study that we analyzed
psychosocial treatment as a single treatment approach, even
though it consists of 4 different psychosocial treatment forms.
Since the offers were equally effective and the 2 groups received
the same variation in treatment offers, we did this to limit the
different outcome possibilities as opposed to limiting any broad
inferences about the effects of offering videoconferencing.
Moreover, it may be both a strength and a limitation to have
chosen videoconferencing as an option in order not to force any
patient to use it. None of the previous similar studies have used
optional videoconferencing; however, blended care is commonly
used in psychiatric treatment. Here, patients reported advantages
such as having met the therapist before or during the treatment
course [12], and optional use of videoconferencing, throughout
the treatment course, offers similar advantages.
Conclusion
The aim of this study was to test whether optional
videoconferencing increases adherence and effect in AUD
treatment. We tested this by examining premature dropout (the
primary outcome), as well as successful treatment termination,
treatment duration, and alcohol characteristics (secondary
outcomes). The results indicate that offering patients optional
videoconferencing may prevent premature dropouts from
treatment and prolong treatment courses. However, the small
sample size precludes conclusions regarding the effect of the
intervention, which was not detectable in the patients’ use of
alcohol and severity of problems. Even though
videoconferencing did not, in this study, seem to lead to a more
effective treatment course, it may be a tool to increase
adherence. Thus, future research is warranted on how
videoconferencing and treatment duration may influence
adherence and effect in AUD treatment.
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